ERBB2 and breast cancer: promote protumorigenic effects in BC; modulate local estrogen-converting enzymes and increase local estrogen levels; cross-talk with HER2 pathway and affect ER signaling to increase pro-oncogenic c-Myc expression in ER+/HER2+ BC cells; alter ER target gene expression and cell viability